Molecular landscape and actionable alterations in a genomic-guided cancer clinical trial: First analysis of the ROME trial.

Authors

null

Andrea Botticelli

Department of Radiology, Oncology and Pathology, “Sapienza” University of Rome, Rome, Italy

Andrea Botticelli , Simone Scagnoli , Pierfranco Conte , Chiara Cremolini , Paolo Antonio Ascierto , Federico Cappuzzo , Massimo Aglietta , Federica Mazzuca , Ettore Capoluongo , Giovanni Blandino , Umberto Malapelle , Marianna Nuti , Giulia D'Amati , Bruna Cerbelli , Giancarlo Pruneri , Mauro Biffoni , Giuseppe Giannini , Francesco Cognetti , Giuseppe Curigliano , Paolo Marchetti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

New Targets and New Technologies (non-IO)

Clinical Trial Registration Number

NCT04591431

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3087)

DOI

10.1200/JCO.2022.40.16_suppl.3087

Abstract #

3087

Poster Bd #

79

Abstract Disclosures